The Inhibitory Neural Circuitry as Target of Antiepileptic Drugs

Author(s): Ingo Bohme, Hartmut Luddens

Journal Name: Current Medicinal Chemistry

Volume 8 , Issue 11 , 2001

Become EABM
Become Reviewer


Impairments and defects in the inhibitory neurotransmission in the CNS can contribute to various seizure disorders, i.e., gama-aminobutyric acid (GABA) and glycine as the main inhibitory neurotransmitters in the brain play a crucial role in some forms of epilepsy. Recent advances in deciphering the molecular basis of the GABAergic and glycinergic systems has been achieved by means of cloning techniques and gene targeting strategies in animals, contributing to the understanding of drug action. As well, several anticonvulsive substances emerged which target key molecules of the inhi- bitory systems. Employment of recombinant expression systems, including, but not restricted to the inhibitory circuitry, will further facilitate drug screening and rational approaches to design novel specific antiepileptic drugs, which act highly efficiently to prevent or reduce generation and spread of seizures.

Keywords: Antiepileptic Drugs, aminobutyric acid (GABA), epilepsy, glutamate decarboxylase, succinic semialdehyde dehydrogenase, Gabapentin, valproate, Ginkgo biloba, Glycine receptor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [1257 - 1274]
Pages: 18
DOI: 10.2174/0929867013372319
Price: $65

Article Metrics

PDF: 2